BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 25726315)

  • 21. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.
    Bell R; Lipham J; Louie B; Williams V; Luketich J; Hill M; Richards W; Dunst C; Lister D; McDowell-Jacobs L; Reardon P; Woods K; Gould J; Buckley FP; Kothari S; Khaitan L; Smith CD; Park A; Smith C; Jacobsen G; Abbas G; Katz P
    Gastrointest Endosc; 2019 Jan; 89(1):14-22.e1. PubMed ID: 30031018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic, deep mural implantation of Enteryx for the treatment of GERD: 6-month follow-up of a multicenter trial.
    Johnson DA; Ganz R; Aisenberg J; Cohen LB; Deviere J; Foley TR; Haber GB; Peters JH; Lehman GA
    Am J Gastroenterol; 2003 Feb; 98(2):250-8. PubMed ID: 12591037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic augmentation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease: multicenter study of the Gatekeeper Reflux Repair System.
    Fockens P; Bruno MJ; Gabbrielli A; Odegaard S; Hatlebakk J; Allescher HD; Rösch T; Rhodes M; Bastid C; Rey J; Boyer J; Muehldorffer S; van den Hombergh U; Costamagna G
    Endoscopy; 2004 Aug; 36(8):682-9. PubMed ID: 15280972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD.
    Triadafilopoulos G; Dibaise JK; Nostrant TT; Stollman NH; Anderson PK; Edmundowicz SA; Castell DO; Kim MS; Rabine JC; Utley DS
    Gastrointest Endosc; 2001 Apr; 53(4):407-15. PubMed ID: 11275878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results : RefluxStop™ device; a new method in acid reflux surgery obtaining CE mark.
    Bjelović M; Harsányi L; Altorjay Á; Kincses Z; Forsell P;
    BMC Surg; 2020 Jul; 20(1):159. PubMed ID: 32689979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic full-thickness plication for the treatment of GERD by application of multiple Plicator implants: a multicenter study (with video).
    von Renteln D; Schiefke I; Fuchs KH; Raczynski S; Philipper M; Breithaupt W; Caca K; Neuhaus H
    Gastrointest Endosc; 2008 Nov; 68(5):833-44. PubMed ID: 18534586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endoscopic full-thickness plication (Plicator) with two serially placed implants improves esophagitis and reduces PPI use and esophageal acid exposure.
    von Renteln D; Brey U; Riecken B; Caca K
    Endoscopy; 2008 Mar; 40(3):173-8. PubMed ID: 18322871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
    Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
    Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.
    Hunter JG; Kahrilas PJ; Bell RC; Wilson EB; Trad KS; Dolan JP; Perry KA; Oelschlager BK; Soper NJ; Snyder BE; Burch MA; Melvin WS; Reavis KM; Turgeon DG; Hungness ES; Diggs BS
    Gastroenterology; 2015 Feb; 148(2):324-333.e5. PubMed ID: 25448925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease.
    Aziz AM; El-Khayat HR; Sadek A; Mattar SG; McNulty G; Kongkam P; Guda MF; Lehman GA
    Surg Endosc; 2010 Apr; 24(4):818-25. PubMed ID: 19730952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring gastroesophageal reflux disease: relationship between the Health-Related Quality of Life score and physiologic parameters.
    Velanovich V; Karmy-Jones R
    Am Surg; 1998 Jul; 64(7):649-53. PubMed ID: 9655276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive effect of abdominal breathing exercise on gastroesophageal reflux disease: a randomized, controlled study.
    Eherer AJ; Netolitzky F; Högenauer C; Puschnig G; Hinterleitner TA; Scheidl S; Kraxner W; Krejs GJ; Hoffmann KM
    Am J Gastroenterol; 2012 Mar; 107(3):372-8. PubMed ID: 22146488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal sphincter device for gastroesophageal reflux disease.
    Ganz RA; Peters JH; Horgan S; Bemelman WA; Dunst CM; Edmundowicz SA; Lipham JC; Luketich JD; Melvin WS; Oelschlager BK; Schlack-Haerer SC; Smith CD; Smith CC; Dunn D; Taiganides PA
    N Engl J Med; 2013 Feb; 368(8):719-27. PubMed ID: 23425164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term and long-term effect of diaphragm biofeedback training in gastroesophageal reflux disease: an open-label, pilot, randomized trial.
    Sun X; Shang W; Wang Z; Liu X; Fang X; Ke M
    Dis Esophagus; 2016 Oct; 29(7):829-836. PubMed ID: 26227494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study.
    Liu S; Chai N; Zhai Y; Zou J; Feng X; Li Z; Li L; Zhang X; Wang X; Wang S; Linghu EQ
    Surg Endosc; 2020 Oct; 34(10):4516-4524. PubMed ID: 31728750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
    Schey R; Alla SP; Midani D; Parkman HP
    Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial.
    Johnson DA; Ganz R; Aisenberg J; Cohen LB; Devière J; Foley TR; Haber GB; Peters JH; Lehman GA
    Am J Gastroenterol; 2003 Sep; 98(9):1921-30. PubMed ID: 14499767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastroesophageal reflux disease-related symptom assessment in subjects with malignant dysphagia receiving esophageal stents.
    North DA; Schlegel M; Martin RC
    Am Surg; 2014 Dec; 80(12):1260-5. PubMed ID: 25513927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
    Noar MD; Lotfi-Emran S
    Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.